Poland· PL-100515319
Emcitate
A tiratricol product containing tiratricolum, registered in Poland by Rare Thyroid Therapeutics International AB. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tiratricol is registered in 10 of 19 countries.
Countries holding a registration under ATC H03AA04 (tiratricol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Tiratricol · ATC H03AA04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Tiratricolum
- Manufacturer
- Rare Thyroid Therapeutics International AB
- Country
- Poland (PL)
- ATC code
- H03AA04
- ATC class
- Tiratricol
- Defined daily dose
- 1.75 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin04150196460358
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tiratricol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEmcitate 350 µgRare Thyroid Therapeutics International
- SpainEMCITATE 350 MICROGRAMOS COMPRIMIDOS DISPERSABLESRare Thyroid Therapeutics International Ab
- FinlandEmcitateRare Thyroid Therapeutics International AB
- IrelandEmcitate 350 microgram dispersible tabletsRare Thyroid Therapeutics International AB
- NetherlandsEmcitate 350 microgram dispergeerbare tablettenRare Thyroid Therapeutics International AB
- NorwayEmcitateRare Thyroid Therapeutics
- SwedenEmcitate 350 mikrogram Dispergerbar tablettRare Thyroid Therapeutics International AB
- CzechiaEMCITATERare Thyroid Therapeutics International AB, Stockholm
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Emcitate
- Liechtenstein · Emcitate
- Norway · Emcitate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/74a7fb2a-b4e0-4159-8f5b-12a210529b31 GET /v1/drugs/74a7fb2a-b4e0-4159-8f5b-12a210529b31?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki do sporządzania zawiesiny doustnej",
"source": "urpl",
"strength": "350 mcg",
"packaging": "Rpz ¦ EU/1/24/1897/001 ¦ 161033\n60 tabl.\n¦ UR/Z/4b/073/26 - 04150196460358",
"substance": "Tiratricolum 350 mcg",
"common_name": "Tiratricolum",
"pl_product_id": "100515319",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about tiratricol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.